American Association of Clinical Endocrinology (AACE) Communities Middle East & North Africa 2025

Comprehensive Endocrinology, Diabetes, Obesity & Metabolic Health Update for the MENA Region

The American Association of Clinical Endocrinology (AACE) Communities Middle East & North Africa 2025 program provides a comprehensive review of the latest advances in endocrinology, diabetes care, obesity medicine, thyroid disorders, bone health, and metabolic disease management.

Held from November 21–23, 2025, at the InterContinental Dubai Festival City, United Arab Emirates, this premier regional meeting brought together leading endocrinologists, diabetes specialists, primary care physicians, and healthcare professionals from across the Middle East, North Africa, and the international endocrine community.

The conference featured more than 50 educational sessions, expert-led lectures, case-based discussions, and practical workshops designed to address the unique clinical challenges faced by healthcare professionals in the MENA region. Special emphasis was placed on diabetes technologies, obesity pharmacotherapy, thyroid cancer management, women’s health, bone disorders, pituitary disease, adrenal disorders, and culturally relevant endocrine care, including the management of patients during Ramadan.

Course Features

• 56 Video Lectures
• 56 Subtitle Files (VTT)
• 54 PDF Presentations
• Total Size: 23.46 GB
• Expert International & Regional Faculty
• Evidence-Based Endocrinology Updates
• Interactive Case Discussions
• Practical Clinical Workshops
• Comprehensive Metabolic Disease Education

Program Overview

Endocrinology continues to evolve rapidly with significant advances in diabetes technologies, obesity therapeutics, precision medicine, endocrine oncology, and metabolic disease management.

The AACE Communities Middle East & North Africa 2025 meeting provides an extensive review of current clinical guidelines, emerging therapies, and evidence-based approaches for diagnosing and managing endocrine disorders across diverse patient populations.

The curriculum emphasizes multidisciplinary care models that integrate lifestyle interventions, nutrition, pharmacotherapy, digital health technologies, artificial intelligence, and patient self-management tools to improve long-term outcomes.

Special attention is given to regional healthcare considerations, helping clinicians address endocrine and metabolic disorders within the unique cultural, dietary, and healthcare environments of the Middle East and North Africa.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Apply multidisciplinary approaches to metabolic disease management.
• Integrate lifestyle medicine and nutrition into endocrine care.
• Utilize diabetes technologies and self-management tools effectively.
• Evaluate emerging diabetes medications and treatment strategies.
• Understand the role of artificial intelligence in diabetes management.
• Diagnose and manage bone mineral disorders using evidence-based approaches.
• Apply current guidelines for thyroid nodules and thyroid cancer.
• Manage complex pituitary and adrenal disorders.
• Integrate multidisciplinary care strategies for endocrine diseases.
• Improve women’s health and menopause management outcomes.

Core Topics Covered

Diabetes Management & Technology

• Continuous Glucose Monitoring (CGM)
• Insulin Pump Therapy
• Artificial Intelligence in Diabetes Care
• Digital Health Solutions
• Advanced Diabetes Pharmacotherapy
• Diabetes Self-Management Education

Obesity Medicine

• Obesity Pharmacotherapy
• Weight Management Strategies
• Metabolic Health Optimization
• Lifestyle Intervention Programs
• Long-Term Obesity Care

Thyroid Disorders & Thyroid Cancer

• Thyroid Nodule Evaluation
• Thyroid Cancer Management
• Evidence-Based Treatment Guidelines
• Complex Thyroid Case Discussions
• Endocrine Oncology Updates

Bone Health & Osteoporosis

• Bone Mineral Disorders
• Osteoporosis Diagnosis
• Fracture Prevention Strategies
• Bone Health Assessment
• Contemporary Treatment Approaches

Pituitary Disorders

• Pituitary Adenomas
• Hormonal Evaluation
• Pituitary Imaging
• Complex Endocrine Cases
• Advanced Management Strategies

Adrenal Disorders

• Adrenal Insufficiency
• Adrenal Tumors
• Hypercortisolism
• Hormonal Disorders
• Evidence-Based Management

Women’s Health & Menopause

• Menopause Management
• Hormonal Health
• Endocrine Aspects of Women’s Health
• Bone Protection Strategies
• Individualized Treatment Planning

Regional Endocrinology Considerations

• Diabetes Management During Ramadan
• Cultural Considerations in Endocrine Care
• Regional Disease Patterns
• Patient Education Strategies
• MENA-Specific Clinical Challenges

Target Audience

This course is ideal for:

• Endocrinologists
• Diabetologists
• Primary Care Physicians
• Internal Medicine Physicians
• Family Medicine Physicians
• Obesity Medicine Specialists
• Diabetes Educators
• Nurse Practitioners
• Physician Assistants
• Healthcare Professionals Involved in Endocrine Care

Educational Highlights

✔ AACE Expert Faculty

✔ International & Regional Endocrinology Leaders

✔ Evidence-Based Clinical Guidelines

✔ Diabetes Technology Education

✔ Interactive Case-Based Learning

✔ Practical Clinical Workshops

✔ Multidisciplinary Treatment Approaches

✔ Regional Endocrinology Perspectives

✔ Obesity & Metabolic Health Updates

✔ Immediate Clinical Application

Why This Course Stands Out

✔ Premier Endocrinology Meeting for the MENA Region

✔ Comprehensive Diabetes & Obesity Updates

✔ Strong Focus on Emerging Technologies

✔ Extensive Thyroid & Endocrine Oncology Education

✔ Practical Regional Clinical Guidance

✔ Evidence-Based Management Strategies

✔ Multidisciplinary Endocrine Care Approach

✔ Valuable for Both Specialists & Primary Care Providers

Clinical & Educational Value

The AACE Communities Middle East & North Africa 2025 meeting delivers an in-depth review of modern endocrinology, diabetes management, obesity medicine, and metabolic healthcare.

By integrating advances in diabetes technology, obesity pharmacotherapy, thyroid cancer management, bone health, pituitary and adrenal disorders, and women’s health, this program equips healthcare professionals with the knowledge necessary to optimize endocrine care and improve patient outcomes.

The combination of international expertise, regional relevance, and practical clinical education makes this conference an outstanding resource for endocrinologists and primary care physicians managing endocrine and metabolic disorders.

 

   Topics

1. Closing Remarks

2. IDS1.A.1 CGM Use in People With and Without Diabetes

3. IDS1.A.2 SGLT2i Use in Type 1 DM

4. IDS1.A.3 GLP1 use in T1DM

5. IDS1.B.1 Menopause Hormone Therapy 101

6. IDS1.B.2 Mood, Sleep and Cognitive Function in Menopause

7. IDS1.B.3 Menopause and Cardiometabolic Risk

8. IDS1.C.1 Molecular Basis of Thyroid Cancer and its Translational Implications

9. IDS1.C.2 What’s New in Medullary Thyroid Cancer

10. IDS1.C.3 Contemporary Management of Graves’ Disease

11. IDS2.A.1 Diabetes and Ramadan An Update

12. IDS2.A.2 Thyroid and Ramadan In Health and Disease

13. IDS2.A.3 Adrenal Replacement in Ramadan

14. IDS2.B.1 Obesity Management in Adolescent

15. IDS2.B.2 From Fat Storage to Fat Burning Exploring the Role of Fasting in Obesity Treatment

16. IDS2.B.3 Approaching Weight Management in Women of Childbearing Age

17. IDS2.C.1 Smoking and Bone Health

18. IDS2.C.2 Osteoporosis in Men

19. IDS2.C.3 Bone Health in Cancer Patients

20. IDS2.D.1 Diabetes Management in the Older Adult

21. IDS2.D.2 Obesity Management in the Elderly

22. IDS2.D.3 When to Treat and When Not to Treat for Thyroid Disease in Geriatrics

23. IDS3.A.1 Mild Autonomous Cortisol Secretion MACS

24. IDS3.A.2 Adrenocortical Cancer New Advances

25. IDS3.A.3 Regional Barriers to Diagnosis and Management of Adrenal Insufficiency

26. IDS3.B.1 Obesity Management in Persons with Special Needs

27. IDS3.B.2 Metabolic and Bariatric Management in Pediatrics

28. IDS3.B.3 Turners Syndrome

29. MTE1.A What’s New in the Approach and Management of Pheochromocytoma Paraganglioma

30. MTE1.B Pituitary Tumors, Biology and Clinical Classification

31. MTE1.C Treatment of Osteoporosis in the Oldest Old

32. MTE2.A Prevention and Cure, Current and Future for Type 1 Diabetes

33. MTE2.B Management of Kidney Disease in Diabetes – An Update

34. MTE2.C Endocrine Practice in Resource – Limited Settings

35. MTE3.A Screening & Management of Metabolic Liver Disease in Endocrine Clinics

36. MTE3.B What is in the Pipeline for Diabetes and Obesity Management

37. MTE3.C Islet Cell Transplant, Innovations in Type 1 Diabetes Management

38. MTE3.D Remission of T2D Through Diet – Is it Real

39. MTE4.ASurgicalHypoparathyroidism

40. MTE4.B Thyroid Autoimmunity and Cardiovascular Risk Beyond Hypothyroidism

41. MTE4.C Beyond BMI The Role of Body Composition Assessment in Obesity Pharmacotherapy

42. MTE4.D Testosterone Replacement – Indications and Challenges

43. MTE5.A Primary Aldosteronism

44. MTE5.B What is the Role for Lifestyle Support in the New Era of Medical Treatment for Obesity

45. MTE5.C Parathyroid in Pregnancy

46. PL1. Acromegaly, Diagnosis, Management and Anomalies

47. PL2. Understanding Sexual Dysfunction in Women with Obesity and Diabetes

48. PL3. Updated Thyroid Nodule and Cancer Guidelines, An Endocrine Surgeon’s Perspective

49. PL4. Indications for SGLT2I and Incretin-Based Therapy Beyond Diabetes Overview and Future Outlook

50. PL5. Congenital Adrenal Hyperplasia

51. PL6. Diagnosis and Management of Hypoparathyroidism

52. PL7. Breaking the Cycle From Fat Cells and Gut to the Mind in Weight Regain

53. Roundtable Discussion – Ali Alzahrani

54. Roundtable Discussion – Samer El-Kaissi

55. Roundtable Discussion – Tamer Elsherbiny

56. Welcome and Opening Ceremony